|
HERC4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.144100E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.430000E-01 |
| Normal-vs-Stage2 |
6.189000E-04 |
| Normal-vs-Stage3 |
2.636100E-02 |
| Normal-vs-Stage4 |
5.114200E-02 |
| Stage1-vs-Stage2 |
5.151100E-04 |
| Stage1-vs-Stage3 |
3.578500E-02 |
| Stage1-vs-Stage4 |
1.166760E-01 |
| Stage2-vs-Stage3 |
7.946500E-02 |
| Stage2-vs-Stage4 |
9.317600E-02 |
| Stage3-vs-Stage4 |
9.588000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.602000E-02 |
| Normal-vs-AfricanAmerican |
9.418800E-01 |
| Normal-vs-Asian |
8.147000E-01 |
| Caucasian-vs-AfricanAmerican |
3.683000E-01 |
| Caucasian-vs-Asian |
3.038400E-01 |
| AfricanAmerican-vs-Asian |
9.109000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.942200E-02 |
| Normal-vs-Female |
1.114030E-01 |
| Male-vs-Female |
5.053000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.761000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.629590E-02 |
| Normal-vs-Age(61-80Yrs) |
2.400600E-03 |
| Normal-vs-Age(81-100Yrs) |
2.140600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.538000E-03 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.395500E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.954000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.967600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.591400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.250800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.709800E-01 |
| Classical-VS-Follicular |
1.783010E-04 |
| Classical-VS-Other |
8.730200E-01 |
| Classical-VS-Normal |
6.947600E-01 |
| Tall-VS-Follicular |
1.009360E-01 |
| Tall-VS-Other |
6.521200E-01 |
| Tall-VS-Normal |
3.682000E-01 |
| Follicular-VS-Other |
1.832980E-01 |
| Follicular-VS-Normal |
9.196100E-04 |
| Other-VS-Normal |
9.996800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.280400E-03 |
| Normal-vs-N1 |
5.652000E-01 |
| N0-vs-N1 |
6.237500E-02 |
|
|
